Evidence map›Paper›PMID 34781010›Full record

ArticleMicrobes and infection

Deficiency in indoleamine-2, 3-dioxygenase induces upregulation of guanylate binding protein 1 and inducible nitric oxide synthase expression in the brain during cerebral infection with Toxoplasma gondii in genetically resistant BALB/c mice but not in genetically susceptible C57BL/6 mice.

Namrata Anand, Jenny Lutshumba, Megan Whitlow, Mohamed H Abdelaziz, Rajesh Mani, Yasuhiro Suzuki

Open access · greenAbstract read
In one paragraph

Article in Microbes and infection. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Identification of novel biomarkers for anti-Frontiers in microbiology · 2024
    Article
  15. Article
  16. Review
  17. Nitric oxide in parasitic infections: a friend or foe?Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Namrata AnandDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Jenny LutshumbaDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Megan WhitlowDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Mohamed H AbdelazizDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Rajesh ManiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA.
Yasuhiro SuzukiDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, 800 Rose Street, Lexington, KY 40536, USA. Electronic address: yasu.suzuki@uky.edu.
University of Kentucky · US

Funding

University of Kentucky Markey Cancer Center Support Grant ECIA SupplementP30CA177558 · NCI · UNIVERSITY OF KENTUCKY · PI Bernard Mark Evers · 2013 to 2026
$38.3M
Cooperation of CD8+ T cells and phagocytes to eliminate Toxoplasma cystsR01AI095032 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2012 to 2023
$4.1M
Key sentinel roles of IFN-gamma production by microglia to orchestrate the innate and T cell-mediated protective immunity to prevent reactivation of cerebral Toxoplasma infectionR56AI152597 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2020 to 2020
$493k
Effector molecules for IFN-gamma-mediated prevention of Toxoplasma proliferation in the brainR21AI134323 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2017 to 2018
$421k
Gender-dependent innate IL-10 production as a key pathogenic factor to promote toxoplasmic encephalitisR21AI136821 · NIAID · UNIVERSITY OF KENTUCKY · PI SUZUKI, YASUHIRO · 2018 to 2019
$421k
NCI NIH HHS P30 CA177558NIAID NIH HHS R01 AI095032NIAID NIH HHS R21 AI134323NIAID NIH HHS R21 AI136821NIAID NIH HHS R56 AI152597
6 · The paper itself

Abstract

We examined the roles of indoleamine-2, 3-dioxygenase 1 (IDO1) in controlling cerebral Toxoplasma gondii infection in both genetically resistant and susceptible strains of mice. In susceptible C57BL/6 mice, IDO expression was immunohistochemically detected only in a minority (22.5%) of tachyzoite-infected cells in their brains during the later stage of infection. When C57BL-6-background IDO1-deficient (IDO1

Indexed as

DioxygenasesToxoplasmaAnimalsBrainGenetic Predisposition to DiseaseIndoleamine-Pyrrole 2,3,-DioxygenaseMiceMice, Inbred BALB CMice, Inbred C57BLNitric Oxide Synthase Type IIUp-RegulationDioxygenasesIndoleamine-Pyrrole 2,3,-DioxygenaseNitric Oxide Synthase Type IIGenetic resistanceGuanylate binding protein 1Indoleamine-2,3-dioxigenaseNitric oxide synthase 2Protective immunityToxoplasma gondii

Identifiers

PMID34781010
PMCPMC9081123
OpenAlexW3213000722

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.